Azin Kheirkhah: New Research on OSE-IgM Antibodies and Age-Related Macular Degeneration
Azin Kheirkhah, Scientist at the Medical University of Innsbruck, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Arteriosclerosis, Thrombosis, and Vascular Biology, adding
“I’m very happy to share that our recent work has been published in Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
This study investigated the association between circulating IgM antibodies against oxidation-specific epitopes (OSEs) and age-related macular degeneration (AMD).
We found that higher levels of OSE-IgM were associated with a lower likelihood of late AMD, suggesting a potential protective role of these antibodies in AMD development and progression.
I’m especially happy to share this publication as it is one of the outcomes of my time in Vienna and a great collaboration between the Medical University of Innsbruck– Florian Kronenberg Lab and the Medical University of Vienna – Christoph Binder Lab.
A big thank you to all co-authors for their contributions, expertise, and collaboration throughout this project. It was a pleasure working together on this!
P.S. A big thank you to Maria Ozsvar Kozma , who helped me with all the measurements! Here’s a little behind-the-scenes look at all the plates used in this study.”
Title: Circulating IgM Antibody Levels Against Oxidation-Specific Epitopes and Their Association With Age-Related Macular Degeneration
Authors: Azin Kheirkhah, Maria Oszvar-Kozma, Claudia Lamina, Klaus J. Stark, Taras Afonyushkin, Martina E. Zimmermann, Caroline Brandl, Iris M. Heid, Florian Kronenberg, Christoph J. Binder
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 25, 2026, 14:12Managing Breakthrough Bleeds in Hemophilia – National Bleeding Disorders Foundation
-
Sep 25, 2026, 13:50Alejandro González Veliz: Beyond the Golden Hour in Stroke Care
-
Sep 25, 2026, 13:32Gevorg Yaghjyan: Low Drug Levels, Higher Cardiovascular Risk in Lupus
-
Sep 25, 2026, 12:53Bastu Odoka: What Happened to Blood Donation?
-
Sep 25, 2026, 12:43Thomas Dayspring: Reshaping the Biology of Atherosclerotic Plaques with New Therapies
-
Sep 25, 2026, 12:14Garima Sharma: Community Clinical Linkages for Better Postpartum Cardiovascular Care
-
Sep 25, 2026, 10:49Shefina S: From Presenting to Hosting at TRANSCON 2026
-
Sep 25, 2026, 10:37Michelle Leona Cecil: Hemophilia Advocacy and the Power of Community
-
Sep 25, 2026, 10:13Michael Baria: Platelet Concentration and PRP Outcomes in Partial Rotator Cuff Tears